Surgical Pledgets Market Size & Share 2025 - 2034

Surgical Pledgets Market Size

The global surgical pledgets market size was valued at USD 768.2 million in 2024 and is expected to exhibit growth at a CAGR of 5.7% from 2025 to 2034 period, owing to the rising number of cardiovascular, orthopedic, and general procedures performed all over the world.

A growing trend towards surgical procedures becoming more frequent with the global rise in elderly people, as well as the expansion in ways wounds can be treated. Additionally, greater surgical skill and advances in techniques are reinforcing the need for surgical pledgets, which are essential in such procedures.

Another trend is the increased emphasis on effective patient treatment while avoiding complications such as hospital infection or wound separation. Such advances have created a major market for surgical pledgets because they are powerful hemostasis and tissue sealing materials.
 

This has been further developed by the fact that regulatory approvals have been granted, and there are now several kinds of pledgets available, such as those made from PTFE, polyester, and Teflon, which have wide-reaching surgical uses. Finally, investment in healthcare and improved hospital structures in the developing world are also factors supporting the growth of this market.
 

Surgical pledgets are supportive tissues or materials bound to the area of tissue where there is defect or damage. The basic ingredients of a modern pledget used in suture materials contain ethylene vinyl acetate copolymer (EVA) combined with silicate and expandable filled polystyrene, polyethylene (PE), and polypropylene (PP). Such glycidyl ether copolymers have been used as modified polymers for oligomeric and polymeric devices because PEM structures are well-known in synthesis.
 

Surgical Pledgets Market Trends

• The number of surgical procedures worldwide is growing significantly owing to the high volume of aging population, resulting in increased demand for surgical tools. This, in turn, causes a market failure which will then shift back to disequilibrium increasing both the price and demand for materials. Similarly, this material is needed for tissue engineering to fill the void that has been created.
   
• Minimally invasive cardiac surgeries have become the preferred option for many due to continuous innovations in the field of medicine, lower rate of complications, and the ability to repair sutures with surgical pledgets, which aids in quicker healing. With cardiovascular diseases being the leading source of death around the globe, the market for surgical pledgets will expand as it follows the principle of catering to patients with better outcomes.
   
• With an increase in the adoption of pledgets, patients, especially those at risk, can be assured that post-operative complications will be at a minimum.
   
• Surgical pledgets are undeniably an important part of the surgical kit as the demand for them increases with rising cases of cardiovascular diseases.
   

Surgical Pledgets Market Analysis

Based on material, the market is segmented as polytetrafluoroethylene (PTFE), polyester, teflon, and other materials. The polytetrafluoroethylene (PTFE) segment is expected to drive business growth and expand at a CAGR of 6.1%, reaching over USD 593.3 million by 2034.
 

• PTFE is especially important because of its great biocompatibility, chemical resistance, and low friction characteristics. These qualities make it ideal for surgery, especially on sensitive tissues where the amount of irritation needs to be limited during surgery and where effective closure of the surgery site is needed. PTFE's properties are especially valuable in orthopedic and cardiovascular surgery where tissues need to be cut and precision is of utmost importance.
   
• Another advantage of using PTFE for making pledgets is the durability and strength they provide. They can be sutured to tissues without fear of tissue damage or suture pull-through, which increases the benefit of post-surgical recovery and minimizes complications.
   
• Additionally, with the evolution of surgical techniques and the increase in minimally-invasive procedures, the flexibility of PTFE becomes even more important. The ability of PTFE to remain intact during complicated surgeries while controlling bleeding increases its demand.
   

Based on application, the surgical pledgets market is segmented as cardiovascular surgery, orthopedic surgery, thoracic surgery, general surgery, and other applications. The cardiovascular surgery segment is expected to drive business growth and expand at a CAGR of 5.9%, reaching over USD 499.1 million by 2034.
 

• The escalating prevalence of coronary artery disease, atherosclerosis, and heart valve disease is increasing the rate of cardiovascular surgeries like coronary artery bypass graft (CABG) and valve repair. These procedures are often associated with significant blood loss and a higher risk of complications, owing to the precise suture technique required. As a result, surgical pledgets are increasingly employed in these procedures to reinforce sutures and control bleeding, enhancing surgical outcomes and minimizing complications.
   
• Another factor positively impacting the growth of the pledget market is the increasing adoption of less invasive cardiovascular procedures. This has led to increased use of advanced surgical pledgets, which are effective hemostatic solutions that minimize tissue injury and surgical recovery time.
   
• Additionally, technology innovation and improvements in operational methods and pledget materials such as absorbable or bioabsorbable pledgets are other reasons fueling the market. To make cardiovascular operations more effective, and most importantly, safer and less invasive, surgical pledgets reinforce anastomoses and sutures to prevent complications, leading to a significant increase in this market segment's share.
   

Learn more about the key segments shaping this market

Download Free PDF

Based on end use, the surgical pledgets market is classified into hospitals, ambulatory surgical centers, and other end users. The hospitals segment dominated the market with a revenue share of 61.7% in 2024.
 

• The bulk of intricate complex surgeries such as cardiovascular, orthopedic, and general surgeries are carried out at healthcare facilities, making them the largest users of Surgical Pledgets as they need reliable wound closure. These institutions perform a range of procedures, both elective and emergency, creating much need for hemostats, tissue reinforcement, and products needed to suppress further complications.
   
• These hospitals tend to have improved medical infrastructure, which warrants wider use of various surgical technologies including specialized surgical pledgets made of PTFE and polyester for better patient outcomes.
   
• Additionally, these hospitals have a greater number of skillful surgical teams, which means more work with advanced and critical high-risk surgeries, calling for better wound care management to avoid complications in the form of infections and bleeding. Putting this all together with the high nature of surgery, improved medical infrastructure, and advanced patient requirements puts the hospitals segment as a critical segment in the market.
   

U.S. surgical pledgets market accounted for USD 255 million in 2024 and is anticipated to grow at a CAGR of 4.5% between 2025 to 2034 period.
 

• Growing attention toward chronic noncommunicable diseases like diabetes, cardiovascular diseases, and obesity has increased the number of patients requiring surgeries complicated with complex wound closure solutions of surgical pledgets. As the population ages, surgeries of an orthopedic, cardiovascular, and general nature that employ pledgets for effective wound healing and reduction of complications also increase in number.
   
• Additionally, the focus of the U.S. healthcare system on improving surgical outcomes and complication reduction serves as an impetus to bolster the market. Innovations in surgical techniques and the shift toward a preference for more noninvasive procedures have further increased the need for reliable and effective wound closure devices. Minimizing bleeding, infection risk, and enhancing recovery are areas where surgical pledgets play a critical role.
   
• Furthermore, the U.S. has many hospitals, ambulatory surgical centers, and specialty clinics which utilize pledgets and have a strong medical backbone.
   

U.K. surgical pledgets market is projected to grow remarkably in the coming years.
 

• An increase in surgeries because of the rising prevalence of chronic diseases such as diabetes, obesity, and cardiovascular ailments is easily becoming commonplace in hospitals. This increase in surgeries has created a correspondingly higher need for surgical pledgets, which are important components for properly closing wounds, achieving hemostasis, and providing tissue support in advanced cardiovascular and orthopedic surgeries.
   
• Constant medical research and improvements in surgical technologies, along with the UK's modernized operational healthcare systems, makes it easier to use specialized surgical pledgets, especially those made from bioabsorptive materials or for specific purposes.
   
• With increased emphasis on patient care, National Health Service (NHS) and other private medical service providers are turning to advanced surgical technology, which increases the availability of quality surgical products in the market.
   

China holds a dominant position in the Asia Pacific surgical pledgets market.
 

• The China construction of medical facilities and services is greatly invested, which leads to a fast-growing healthcare infrastructure in China that supports an increasing requirement for surgical products such as pledgets.
   
• Furthermore, the rising number of surgical centers and hospitals, as well as innovation in medical technologies, supports the use of more sophisticated surgical instruments, which includes the usage of PTFE and polyester-based pledgets.
   
• Additionally, China's increasing surgical pledget demand is fueled by its growing elderly population since older people tend to undergo surgeries more often. Government efforts to increase healthcare accessibility and quality, especially in rural and deficient areas, will further support this development. In view of the fact that the country continues to advance its healthcare system and improve the skills of its medical personnel, the market in China is expected to achieve constant growth.
   

Surgical Pledgets Market Share

The market is led by certain dominant businesses which are known for their sophisticated products and international presence. These players include Johnson & Johnson MedTech (Ethicon), B. Braun Melsungen AG, and Medtronic, who command market shares owing to their robust products and wide distribution channels. These companies are at the forefront of the market with their advanced wound closure innovations such as the PTFE and polyester pledgets, which have various applications in surgical procedures.
 

Surgical Pledgets Market Companies

Prominent players operating in the surgical pledgets industry include:

• B. Braun
• Becton, Dickinson and Company
• DeRoyal
• Dolphin Sutures
• Gore
• Henry Schein
• Johnson and Johnson
• Medline
• Medtronic
• Peters Surgical
• Teleflex

USPs of the top market players

• B Braun provides quality surgical services such as surgical pledgets that are designed with the latest technology in order to hemostatically control bleeding while limiting tissue damage. With their expertise in the development of new surgical products, they remain valuable partners to healthcare practitioners all over the world.
   
• The Ethicon division of Johnson and Johnson produces high quality surgical pledgets based on many years of experience in suturing and wound closure. They have a systematic approach to R&D that enables them to develop advanced, dependable, and safe products for complicated surgeries.
   

Surgical Pledgets Industry News:

• In March of 2024, Advanced Medical Solutions Group plc (AMS), a tissue repair technologies company, acquired Peters Surgical from Euranzeo. This acquisition was expected to enhance the range of surgical products including surgical pledgets, providing enhanced safety for patients and ease for surgeons.
   
• In April 2023, Aziyo Biologics, Inc. announced a distribution partnership with LeMaitre Vascular, Inc. a provider of vascular devices and services. With this contract, LeMaitre was given the exclusive right to sell all of Aziyo's products in the U.S., which includes Tyke, the first extracellular anti-adhesion matrix for neonatal and infant patch, pledget, and intracardiac surgery.
   

The surgical pledgets market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million and from 2021 – 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Material

• Polytetrafluoroethylene (PTFE)
• Polyester
• Teflon
• Other materials

Market, By Application

• Cardiovascular surgery
• Orthopedic surgery  
• Thoracic surgery
• General surgery
• Other applications

Market, By End Use

• Hospitals
• Ambulatory surgical centers
• Other end users

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE